Alliance Pharma Dividends - APH

Alliance Pharma Dividends - APH

Buy
Sell
Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Alliance Pharma Plc APH London Ordinary Share GB0031030819 ORD 1P
  Price Change Price Change % Stock Price Last Trade
-0.70 -0.81% 85.30 15:56:09
Open Price Low Price High Price Close Price Previous Close
84.70 84.00 86.00 86.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Alliance Pharma APH Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
22/09/2020InterimGBX0.5331/12/201931/12/202017/12/202018/12/202007/01/20210
24/09/2019InterimGBX0.5431/12/201831/12/201919/12/201920/12/201910/01/20200.54
26/03/2019FinalGBX0.9831/12/201731/12/201813/06/201914/06/201911/07/20191.47
19/09/2018InterimGBX0.48731/12/201731/12/201820/12/201821/12/201810/01/20190
27/03/2018FinalGBX0.8931/12/201631/12/201714/06/201815/06/201811/07/20181.33
13/09/2017InterimGBX0.4431/12/201631/12/201721/12/201722/12/201711/01/20180
29/03/2017FinalGBX0.80731/12/201531/12/201615/06/201716/06/201712/07/20171.21
14/09/2016InterimGBX0.40331/12/201531/12/201622/12/201623/12/201612/01/20170
07/04/2016FinalGBX0.7431/12/201431/12/201516/06/201617/06/201613/07/20161.1
09/09/2015InterimGBX0.3631/12/201431/12/201524/12/201529/12/201514/01/20160
25/03/2015FinalGBX0.6731/12/201331/12/201418/06/201519/06/201515/07/20151
10/09/2014InterimGBX0.33331/12/201331/12/201403/12/201405/12/201415/01/20150
26/03/2014FinalGBX0.6131/12/201231/12/201311/06/201413/06/201410/07/20140.91
11/09/2013InterimGBX0.30331/12/201231/12/201304/12/201306/12/201315/01/20140
21/03/2013FinalGBX0.5531/12/201131/12/201212/06/201314/06/201311/07/20130.83
12/09/2012InterimGBX0.27531/12/201131/12/201205/12/201207/12/201215/01/20130
22/03/2012FinalGBX0.531/12/201031/12/201113/06/201215/06/201212/07/20120.75
07/09/2011InterimGBX0.2531/12/201031/12/201130/11/201102/12/201113/01/20120
23/03/2011FinalGBX0.431/12/200931/12/201015/06/201117/06/201114/07/20110.57
08/09/2010InterimGBX0.1731/12/200931/12/201001/12/201003/12/201014/01/20110
24/03/2010FinalGBX0.2331/12/200831/12/200916/06/201018/06/201015/07/20100.3
09/09/2009InterimGBX0.0730/12/200830/06/200902/12/200904/12/200915/01/20100

Top Dividend Posts

DateSubject
18/2/2021
09:52
2vdm: RNSthis a.m.: Alliance Pharma plc (AIM: APH), the international healthcare group, will announce its results for the 12 months ended 31 December 2020 on Tuesday 23 March 2021. A conference call for analysts will be held at 10.30am on 23 March 2021; analysts who require dial-in details, please contact Buchanan at alliancepharma@buchanan.uk.com. A recorded webcast of the analyst conference call, including investor presentation slides, will be made available during the afternoon of 23 March 2021 at this link: hxxps://webcasting.buchanan.uk.com/broadcast/60180f8da6bfbf43d06ac2ea The recorded webcast will also be made available at the investor section of Alliance's website, hxxps://www.alliancepharmaceuticals.com/investors/. For more information, please contact Buchanan on 020 7466 5000 or email alliancepharma@buchanan.uk.com.
04/1/2021
23:27
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes APH and some others with a similar business model. We also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Anyway, if you use Youtube, Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 39) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !! Happy New Lockdown !! WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-39-2064-profit-aph-clin-merc-pdd-axs-som-itm-adm-swg-vle-ai
29/12/2020
22:40
wba1: Interesting acquisition. I have held this share for a few years, having bought in the low 40s. I originally bought as the business model bears some resemblance (although more OTC focused) to Galen, a company which made me very good profits in the early 2000s. And the more I see of APH the more it behaves like Galen - low risk, throws off free cash flow reliably and makes few mistakes in its dealings. I suspect this deal will be the last until 2022 and I may look to slice some profit if it tops 100p.
25/9/2020
06:50
2vdm: Also reduced my holdings substantially. I've done very well out of APH and still hold, but I can't see it going anywhere at the moment, although I may re-visit when we have more news
22/9/2020
16:44
winnings1: AMUNRO- What stock did you buy to replace APH, did it work out o.k. for you?
22/9/2020
08:54
amunro: Tesla is an interesting one. Are they are a car maker or innovator of next gen technology like self driving cars and batteries? As an investor sometimes you just need to follow the market, make money, with the view to getting out when things dive. Its all about managing risk. I got out of APH as I want the money to grow faster than APH offers.
22/9/2020
08:38
winnings1: I consider APH a sound and quite safe stock in the turbulent markets - of which we have seen some signs yesterday, and almost certainly more turbulance to come, IMHO. In fact, also in the unit trusts terratory, I am mainly invested in the health sector (e.g. Schroder Global Healthcare unit trust). I would, for example, not touch a madly overvalued stock like Tesla, where there is a chance of an implosion some day. We are living in weird times, some shere prices rising out of the pan, yet no certainty anywhere. Take care, keep healthy. Cheeers, WS
09/4/2020
10:05
scillyfool: 2vdm, I'm sure APH have their eyes on prospective struggling competitors, but as the integration of Nizoral won't be completed uhtil June I just thought that they should concentrate on getting that integrated before taking on further acquisitions. My own thoughts are that in future many previous company development strategies may need to be rethought. First priority - survival. A company with no debt and a cash pile can better survive any market shocks and not only keep investors happy by continuing to pay dividends, but perhaps be even better placed to buy struggling competitors. Let's hope that after all this Covid-19 is over APH pay a special dividend to their loyal shareholders equal to the pulled final dividend to reassure us.
08/4/2020
06:36
2vdm: Scilly, although what you say makes sense, there may be some excellent products/companies that find themselves struggling and APH may be in a position to acquire them/their products at a knock down price. It's a balance to be considered.
30/3/2020
20:58
scillyfool: Seeing the bottom of this bear market is going to be difficult with the US lagging in the coronavirus spread. The convential wisdom is to only buy "when there is blood on the streets", I'm not looking forward to that in the US and certainly hope that doesn't happen here. The financial basics of APH still look sound to me. It's just a question of timing now.
ADVFN Advertorial
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210226 16:16:21